Ferroptosis-related gene signature-based subtype identification of triple-negative breast cancer to prioritize treatment strategies
PurposeFerroptosis, an iron-dependent form of regulated cell death (RCD), has been proven to affect the response to antineoplastic therapies. However, little is known about the role of ferroptosis in chemotherapy and immune checkpoint inhibitor (ICI) therapy responses, as well as the molecular subty...
Saved in:
| Main Authors: | Yongzhen Chen, Xiaoying Huang, Junqi Wang, Chao Hu, Yanan Zheng, Yumeng Wang, Shuqian Zheng, Guozhong Ji, Qiang You |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1541119/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
by: Jialin Yuan, et al.
Published: (2025-01-01) -
Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01) -
THEM6 modulates carboplatin sensitivity by regulating ferroptosis through FDFT1 in triple-negative breast cancer
by: Yuexiang Zeng, et al.
Published: (2025-07-01) -
Dual-ferroptosis induction-based microneedle patches for enhanced chemodynamic/photothermal combination therapy against triple-negative breast cancer
by: Yujie Wang, et al.
Published: (2025-08-01) -
Bioinformatics analysis for immune hub genes in BLIS subtype of triple-negative breast cancer
by: Hend Adel, et al.
Published: (2025-07-01)